Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation

Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation

The aim of the study is to evaluate the efficacy of different lines of therapies on the TWEAK serum level in patients with non-segmental vitiligo.

the study is to evaluate the efficacy of NB-UVB, latanoprost, and combination of them on the TWEAK serum level in patients with non-segmental vitiligo.

Inclusion Criteria:

• Patients with non-segmental vitiligo of any age and gender.

Exclusion Criteria:

• History of vitiligo treatment with topical, systemic or biological agents prior to the study for at least 3 weeks.
• Pregnancy and lactation.
• Infections
• Patients with other autoimmune diseases.
• Patients with chronic diseases: cardiac diseases, hepatic disorders, hematologic disease, chronic renal failure or malignancies.